Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.5600
-0.0400 (-6.67%)
Mar 4, 2026, 4:00 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Nov '17 Nov '16 Nov '15 Nov '14
Octomera
68.00K35.17M35.07M--
Octomera Growth
-99.81%0.29%---
Therapies
515.00K6.43M11.93M--
Therapies Growth
-91.99%-46.06%---
Eliminations
-53.00K-5.58M-11.49M--
Point-Of-Care Business
---7.65M3.90M
Point-Of-Care Business Growth
---96.26%-
Total
530.00K36.03M35.50M7.65M3.90M
Total Growth
-98.53%1.47%363.96%96.26%-82.46%
Source: S&P Global Market Intelligence.